Persistence of Leukemia-Initiating Cells in a Conditional Knockin Model of an Imatinib-Responsive Myeloproliferative Disorder

Cancer Cell

Volumn 16, Issue 2, 2009, Pages 137-148

  Oravecz Wilson, Katherine I ^a   Philips, Steven T ^a   Yilmaz, Ömer H ^a   Ames, Heather M ^a   Li, Lina ^a   Crawford, Brendan D ^a   Gauvin, Alice M ^a   Lucas, Peter C ^a   Sitwala, Kajal ^a   Downing, James R ^b   Morrison, Sean J ^a   Ross, Theodora S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

CELLCYCLE; STEMCELL

Indexed keywords

IMATINIB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR RUNX1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER MODEL; CANCER RESISTANCE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG RESPONSE; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSDUCTION; IMMUNOPHENOTYPING; LEUKEMIA CELL; LEUKEMIA INITIATING CELL; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; ONCOGENE; PRIORITY JOURNAL;

MUS;

EID: 67651166902     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2009.06.007     Document Type: Article

References (32)

1. Breuer M., Wientjens E., Verbeek S., Slebos R., and Berns A. Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras. Cancer Res. 51 (1991) 958-963
2. Cano F., Drynan L.F., Pannell R., and Rabbitts T.H. Leukaemia lineage specification caused by cell-specific Mll-Enl translocations. Oncogene 27 (2008) 1945-1950
3. Chen W., Kumar A.R., Hudson W.A., Li Q., Wu B., Staggs R.A., Lund E.A., Sam T.N., and Kersey J.H. Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells. Cancer Cell 13 (2008) 432-440
4. Curtis C.E., Grand F.H., Waghorn K., Sahoo T.P., George J., and Cross N.C. A novel ETV6-PDGFRB fusion transcript missed by standard screening in a patient with an imatinib responsive chronic myeloproliferative disease. Leukemia 21 (2007) 1839-1841
5. Druker B.J., Guilhot F., O'Brien S.G., Gathmann I., Kantarjian H., Gattermann N., Deininger M.W., Silver R.T., Goldman J.M., Stone R.M., et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N. Engl. J. Med. 355 (2006) 2408-2417
6. Gilliland D.G. Molecular genetics of human leukemias: new insights into therapy. Semin. Hematol. 39 (2002) 6-11
7. Golub T.R., Barker G.F., Lovett M., and Gilliland D.G. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77 (1994) 307-316
8. Grand F.H., Burgstaller S., Kuhr T., Baxter E.J., Webersinke G., Thaler J., Chase A.J., and Cross N.C. p53-Binding protein 1 is fused to the platelet-derived growth factor receptor beta in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorder. Cancer Res. 64 (2004) 7216-7219
9. Grisolano J.L., O'Neal J., Cain J., and Tomasson M.H. An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice. Proc. Natl. Acad. Sci. USA 100 (2003) 9506-9511
10. Higuchi M., O'Brien D., Kumaravelu P., Lenny N., Yeoh E.J., and Downing J.R. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell 1 (2002) 63-74
11. Huettner C.S., Zhang P., Van Etten R.A., and Tenen D.G. Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat. Genet. 24 (2000) 57-60
12. Jaiswal S., Traver D., Miyamoto T., Akashi K., Lagasse E., and Weissman I.L. Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias. Proc. Natl. Acad. Sci. USA 100 (2003) 10002-10007
13. Jorgensen H.G., Copland M., Allan E.K., Jiang X., Eaves A., Eaves C., and Holyoake T.L. Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in vitro promotes their elimination by imatinib mesylate. Clin. Cancer Res. 12 (2006) 626-633
14. Kavalerchik E., Goff D., and Jamieson C.H. Chronic myeloid leukemia stem cells. J. Clin. Oncol. 26 (2008) 2911-2915
15. Kogan S.C., Ward J.M., Anver M.R., Berman J.J., Brayton C., Cardiff R.D., Carter J.S., de Coronado S., Downing J.R., Fredrickson T.N., et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 100 (2002) 238-245
16. Kuhn R., Schwenk F., Aguet M., and Rajewsky K. Inducible gene targeting in mice. Science 269 (1995) 1427-1429
17. Lee B.H., Tothova Z., Levine R.L., Anderson K., Buza-Vidas N., Cullen D.E., McDowell E.P., Adelsperger J., Frohling S., Huntly B.J., et al. FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia. Cancer Cell 12 (2007) 367-380
18. Li L., Piloto O., Nguyen H.B., Greenberg K., Takamiya K., Racke F., Huso D., and Small D. Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model. Blood 111 (2008) 3849-3858
19. Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., and Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 88 (1991) 10431-10434
20. Neering S.J., Bushnell T., Sozer S., Ashton J., Rossi R.M., Wang P.Y., Bell D.R., Heinrich D., Bottaro A., and Jordan C.T. Leukemia stem cells in a genetically defined murine model of blast-crisis CML. Blood 110 (2007) 2578-2585
21. Oravecz-Wilson K.I., Kiel M.J., Li L., Rao D.S., Saint-Dic D., Kumar P.D., Provot M.M., Hankenson K.D., Reddy V.N., Lieberman A.P., et al. Huntingtin Interacting Protein 1 mutations lead to abnormal hematopoiesis, spinal defects and cataracts. Hum. Mol. Genet. 13 (2004) 851-867
22. Reilly J.T. Receptor tyrosine kinases in normal and malignant haematopoiesis. Blood Rev. 17 (2003) 241-248
23. Ross T.S., Bernard O.A., Berger R., and Gilliland D.G. Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2). Blood 91 (1998) 4419-4426
24. Ross T.S., and Gilliland D.G. Transforming properties of the Huntingtin interacting protein 1/ platelet-derived growth factor beta receptor fusion protein. J. Biol. Chem. 274 (1999) 22328-22336
25. Savona M., and Talpaz M. Getting to the stem of chronic myeloid leukaemia. Nat. Rev. Cancer 8 (2008) 341-350
26. Sawyers C.L., Gishizky M.L., Quan S., Golde D.W., and Witte O.N. Propagation of human blastic myeloid leukemias in the SCID mouse. Blood 79 (1992) 2089-2098
27. Schessl C., Rawat V.P., Cusan M., Deshpande A., Kohl T.M., Rosten P.M., Spiekermann K., Humphries R.K., Schnittger S., Kern W., et al. The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice. J. Clin. Invest. 115 (2005) 2159-2168
28. Sirard C., Lapidot T., Vormoor J., Cashman J.D., Doedens M., Murdoch B., Jamal N., Messner H., Addey L., Minden M., et al. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 87 (1996) 1539-1548
29. Tefferi A., and Gilliland D.G. Oncogenes in myeloproliferative disorders. Cell Cycle 6 (2007) 550-566
30. Wolff N.C., and Ilaria Jr. R.L. Establishment of a murine model for therapy-treated chronic myelogenous leukemia using the tyrosine kinase inhibitor STI571. Blood 98 (2001) 2808-2816
31. Yan M., Kanbe E., Peterson L.F., Boyapati A., Miao Y., Wang Y., Chen I.M., Chen Z., Rowley J.D., Willman C.L., and Zhang D.E. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat. Med. 12 (2006) 945-949
32. Yilmaz O.H., Valdez R., Theisen B.K., Guo W., Ferguson D.O., Wu H., and Morrison S.J. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441 (2006) 475-482